Self-rated health before and after retirement in France (GAZEL): a cohort study
Background
Governments need to increase the proportion of the population in work in most developed countries because of ageing populations. We investigated longitudinally how self-perceived health is affected by work and retirement in older workers.
Methods
We examined trajectories of self-rated health in 14 714 employees (11 581 [79%] men) from the French national gas and electricity company, the GAZEL cohort, for up to 7 years before and 7 years after retirement, with yearly measurements from 1989 to 2007. We analysed data by use of repeated-measures logistic regression with generalised estimating equations.
Findings
Overall, suboptimum health increased with age. However, between the year before retirement and the year after, the estimated prevalence of suboptimum health fell from 19·2% (95% CI 18·5—19·9) to 14·3% (13·7—14·9), corresponding to a gain in health of 8—10 years. We noted this retirement-related improvement in men (odds ratio 0·68, 95% CI 0·64—0·73) and women (0·74, 0·67—0·83), and across occupational grades (low 0·72, 0·63—0·82; high 0·70, 0·63—0·77), and it was maintained throughout the 7 years after retirement. A poor work environment and health complaints before retirement were associated with a steeper yearly increase in the prevalence of suboptimum health while still in work, and a greater retirement-related improvement; however, people with a combination of high occupational grade, low demands, and high satisfaction at work showed no such retirement-related improvement.
Interpretation
These findings suggest that the burden of ill-health, in terms of perceived health problems, is substantially relieved by retirement for all groups of workers apart from those with ideal working conditions, and that working life for older workers needs to be redesigned to achieve higher labour-market participation.
Funding
Swedish Council for Working Life and Social Research, Academy of Finland, INSERM (France), BUPA Foundation (UK), European Science Foundation, and Economic and Social Research Council (UK).
Similar entries
- Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer
- Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national meta-regression analysis
- Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study
- PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab...
- Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke
- The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
- Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study
- Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, trial
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin)...





